Franklin.ai Glass integrates with traditional histopathology, enhancing tissue analysis and diagnostic precision in AI Microscopy.
Predictions indicate that the number of new cases of prostate cancer will reach 35 million by 2050 (77% increase)*.
With pathologists responsible for diagnosing 100% of all cancers, their workloads are set to increase.
* Global cancer statistics 2022: GLOBOCAN estimates and mortality worldwide for 36 cancers in 185 countries.
Franklin.ai Glass seamlessly integrates AI with traditional Microscopy, enhancing the efficiency and accuracy of pathology workflows. By providing AI-powered analysis directly from glass slide samples, Franklin.ai Glass eliminates the need for costly digital scanners while still enabling advanced tissue assessment. With real-time insights, automated detection of clinically relevant findings, and support for pathologists at every stage, Franklin.ai Glass brings the power of AI Microscopy into everyday practice.
Did you know it can take over 10 years to train a pathologist? Whilst we can seek to address the shortage of pathologists, there's going to be a lag between the next generation of these much needed clinicians.
With rising caseloads in mind, Franklin.ai exists to streamline and scale the work pathologists can do. AI-assisted microscopy solutions help optimise workflows, reducing diagnostic turnaround times while maintaining accuracy. Our goal is to help unlock more healthcare capacity.
We want to create a world where more patients are on the right treatment pathway, thanks to the speed and precision of AI-powered diagnosis.
Harrison.ai was founded in 2018 by Dr Aengus Tran and Dimitry Tran. Prior to that, Dimitry had spent over a decade working in global healthcare and strategy; Aengus completed his medical training with distinction at the University of New South Wales in Sydney.
Witnessing first hand the gap between capacity of expert clinicians and demand they founded Harrison.ai. Their mission? To urgently scale global healthcare capacity, using A.I. automation. Their passion for computer science combined with deep medical expertise and the desire to change the world drove them onto the next chapter in the story - the founding of Franklin.ai in 2022, bringing AI-assisted microscopy to the forefront of digital pathology.
Every clinician, lab, hospital, technician, and member of the medical device community that works with us is helping to create a world where pathologists can perform at their best. By integrating AI-assisted microscopy into traditional workflows, we’re enhancing diagnostic precision and efficiency, ensuring more patients receive the timely, accurate care they deserve.
With the growing demand for pathology services and rising caseloads, solutions like Franklin.ai Glass are critical in expanding healthcare capacity. By providing AI-powered analysis directly from glass slides, our technology eliminates the need for costly digital scanners. Franklin.ai Glass supports pathologists with real-time insights, automated detection of clinically relevant findings, and seamless collaboration across teams. Alongside our Decision Support AI solutions, Franklin.ai is transforming pathology workflows to improve speed, accuracy, and accessibility in diagnostics.
Learn more about our Pathology AI solutions.
By leveraging Harrison.ai's stable and proven A.I. technology, we can accelerate future product development at the highest levels of quality. We are building a platform at Franklin.ai that aims to improve efficiencies across all areas of pathology, starting with histopathology.
We understand laboratories want choices in the vendors they work with. We partner and integrate with your suppliers of choice to ensure a seamless digital pathology solution.
